BDH Industries Ltd - Stock Valuation and Financial Performance

BSE: 524828 | NSE: MBIND | Pharmaceuticals & Drugs | Small Cap

BDH Inds Share Price

287.95 -3.95 -1.35%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on BDH Inds

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

BDH Industries stock performance -

mw4me loader
P/E Ratio (SA):
19.07
Market Cap:
168.1 Cr.
52-wk low:
108.2
52-wk high:
372.1

Is BDH Industries Ltd an attractive stock to invest in?

1. Is BDH Industries Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that BDH Industries Ltd is a average quality company.

2. Is BDH Industries Ltd undervalued or overvalued?

The key valuation ratios of BDH Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is BDH Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of BDH Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of BDH Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
BDH Industries Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.8%8.6%9.9%9.6%10.3%12.1%13.6%13.2%13.8%15.1%-
Value Creation
Index
-0.4-0.4-0.3-0.3-0.3-0.10.0-0.10.00.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 42.644.646.143.74151.759.557.569.474.581
Sales YoY Gr.-4.6%3.4%-5.3%-6.1%26%15.1%-3.4%20.8%7.3%-
Adj EPS 44.55.65.86.58.410.311.11214.315.3
YoY Gr.-11.5%25.1%3.9%12.8%28.3%23%7.1%8.6%18.8%-
BVPS (₹) 37.33944.64851.656.963.772.282.192.7100.7
Adj Net
Profit
2.32.63.23.33.84.85.96.46.98.29
Cash Flow from Ops. 3.96.24.37.2-0.2-3.611.40.836.3-
Debt/CF from Ops. 2.91.42.21.2-51.5-3.60.810.90.80.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.4%12.7%7.8%7.3%
Adj EPS 15.2%16.9%11.4%18.8%
BVPS10.6%12.5%13.3%13%
Share Price 30.7% 30.3% 48.5% 162.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
10.210.912.511.812.514.716.415.615.115.915.8
Op. Profit
Mgn %
8.68.58.91113.113.615.114.813.114.713.7
Net Profit
Mgn %
5.45.877.69.29.31011.1101110.8
Debt to
Equity
0.50.40.40.30.30.40.30.20.10.1-
Working Cap
Days
127132126111132155146156154160138
Cash Conv.
Cycle
130-18-34-44-13-4-68679

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 15.80%

Net Profit is growing at healthy rate in last 3 years 11.36%

Sales growth is good in last 4 quarters at 21.41%

Sales growth has been subdued in last 3 years 7.77%

Latest Financials - BDH Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 15.3 -
TTM Sales (₹ Cr.) 81.4 -
BVPS (₹.) 100.7 -
Reserves (₹ Cr.) 52 -
P/BV 2.90 -
PE 19.07 -
From the Market
52 Week Low / High (₹) 108.20 / 372.05
All Time Low / High (₹) 2.45 / 372.05
Market Cap (₹ Cr.) 168
Equity (₹ Cr.) 5.8
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of BDH Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of BDH Inds

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales43454644415259576974
Operating Expenses 39414239364551496064
Manufacturing Costs89877997810
Material Costs22232423202731334444
Employee Cost 4556677677
Other Costs 5543233323
Operating Profit 44455799911
Operating Profit Margin (%) 8.6%8.5%8.9%11.0%13.1%13.5%15.1%14.8%13.1%14.7%
Other Income 1121111111
Interest 1000011000
Depreciation 1111111111
Exceptional Items 0000000000
Profit Before Tax 345557891011
Tax 1122122223
Profit After Tax 2333456678
PAT Margin (%) 5.4%5.8%7.0%7.6%9.2%9.3%10.0%11.1%10.4%11.0%
Adjusted EPS (₹)4.04.55.65.86.58.410.311.112.614.3
Dividend Payout Ratio (%)30%38%36%35%34%33%24%27%29%28%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 23242729313438434955
Share Capital 6666666666
Reserves 17182123252832374349
Minority Interest0000000000
Debt119988139925
Long Term Debt0001000000
Short Term Debt119987139925
Trade Payables10151314161616171619
Others Liabilities 3323222222
Total Liabilities 48525254576665716980

Fixed Assets

Gross Block24242535363636363636
Accumulated Depreciation9111212131415161617
Net Fixed Assets15131323232221202019
CWIP 0040000000
Investments 0000000000
Inventories5553685577
Trade Receivables8108871311151517
Cash Equivalents 18212019171723231926
Others Assets32214657911
Total Assets 48525254576665716980

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 46470-411136
PBT 345557891011
Adjustment 2110001000
Changes in Working Capital 1304-4-95-5-3-2
Tax Paid -1-1-2-2-1-2-2-2-3-3
Cash Flow From Investing Activity 00-5-5011110
Capex 00-5-7000010
Net Investments 0000000000
Others 0001111111
Cash Flow From Financing Activity 3-3-1-3-33-6-2-80
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0001-100000
Interest Paid 00000-1-1000
Dividend Paid -1-1-1-1-1-1-2-1-2-2
Others 4-21-205-4-1-63
Net Cash Flow 63-1-1-2060-47
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)11.0211.6913.412.5113.1315.4617.1116.2616.2716.31
ROCE (%)13.5513.2515.3914.914.7416.9419.1418.7419.6120.84
Asset Turnover Ratio0.960.90.90.840.740.840.910.840.991
PAT to CFO Conversion(x)221.332.330-0.81.830.170.430.75
Working Capital Days
Receivable Days71727065677072837876
Inventory Days36414132414939333234
Payable Days166207213219271221187183141148

BDH Industries Ltd Stock News

BDH Industries Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of BDH Inds on 28-Mar-2024 16:01 is ₹287.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of BDH Inds stood at ₹168.1.
The latest P/E ratio of BDH Inds as of 28-Mar-2024 16:01 is 19.07.
The latest P/B ratio of BDH Inds as of 28-Mar-2024 16:01 is 2.90.
The 52-week high of BDH Inds is ₹372.1 and the 52-week low is ₹108.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of BDH Inds is ₹81.44 ( Cr.) .

About BDH Industries Ltd

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.

Products offered by the Company:

Some of its therapeutical categories are:

1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables

It also manufactures sildenafil citrate tablets for male impotency

Achievements:

  • The Government of the India has accorded 'Star Export House' status to the company
  • The Government of India also accredited the company with WHO-GMP Certification since 1982.
  • It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
  • The company has received Chemexcil Top Export Award
  • It has also received Chemexcil Trishul Award for Consistent Export Performance
  • It has received the Government of Maharashtra's Export Award
  • Ministry of Commerce's Award from the President of India was conferred on the company.
  • 2010
    • BDH Industries won ‘Good Corporate Citizen’ Award by Bombay Chamber of Commerce & Industry 2010
    • BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
    • WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.